site stats

Ims pharmetrics plus database

Witryna1 wrz 2014 · Methods: Adult patients with ≥1 diagnosis of MCL and ≥1 claim for a medication used to treat MCL were identified in the IMS PharMetrics Plus database (January 2008 - September 2013). Patients were excluded if they had evidence of a non-hematologic malignancy, used a non-MCL antineoplastic agent, or received a stem … Witryna20 maj 2016 · Methods: Two retrospective cohort studies were independently conducted using IMS PharMetrics Plus databases and MarketScan commercial and Medicare supplemental databases. Patients included those aged ≥ 18 years who had ≥ 1 metastatic melanoma diagnosis and ≥ 1 claim for any systemic therapies from July 1, …

Costs associated with adverse events for systemic therapies in ...

WitrynaMethods: NVAF patients who initiated apixaban, rivaroxaban, dabigatran, or warfarin were identified from the IMS Pharmetrics Plus database (January 1, 2013 … Witryna5 lis 2024 · Methods: We analyzed data from subjects enrolled in the IMS PharMetrics Plus Database of medical insurance claims between July 2013 and June 2015. dynamix gymnastics st. albert https://steve-es.com

Treatment Failure Patterns in Patients with Mantle Cell Lymphoma ...

Witryna25 sty 2024 · The PharMetrics Plus database holds pharmacy, provider, and facility claims for approximately 150 million patients enrolled in US health insurance plans, with an annual capture of ~40 million. Of these patients, 97% are commercially insured, 2% have Medicare Advantage coverage, and 1% have Medicaid coverage. Witryna8 kwi 2024 · PharMetrics Plus is IQVIA’s longitudinal health plan database of adjudicated medical and pharmacy claims, including patient enrollment data. With … WitrynaMaterials and methods: A retrospective claims-based analysis was conducted using IMS Pharmetrics Plus database. Included patients were ≥18 years old, with a diagnosis … cs4 photoshop for pc

Full article: Patterns of use of systemic therapies among patients …

Category:IQVIA PharMetrics® Plus - IQVIA

Tags:Ims pharmetrics plus database

Ims pharmetrics plus database

Characterization of Hysterectomy in Women with VWD

Witryna6 sty 2024 · Data are from the IMS Health PharMetrics Plus Database, which contains individual-level, de-identified health care claims information from employers, hospitals, and health plans on more than 150 million commercially insured patients in the United States. Data were extracted for medical claims for VWD (ICD-9 286.4), other bleeding … WitrynaIn each database, patients were identified who met the following criteria: adults (aged 18 years) with nonvalvular atrial fibrillation who had a pharmacy claim for apixaban or warfarin during the identification period (January 1, 2013 to September 30, 2015). The first apixaban or warfarin prescription claim date was defined as the index date.

Ims pharmetrics plus database

Did you know?

WitrynaPharMetrics Plus for MedTech is IQVIA’s longitudinal health plan database of adjudicated integrated medical and pharmacy claims, offered specifically for MedTech … Witryna6 sty 2024 · Data are from the IMS Health PharMetrics Plus Database, which contains individual-level, de-identi fi ed health care claims information from employers, hospitals, and health

Witryna19 sty 2024 · A retrospective cohort analysis was conducted using the IMS PharMetrics Plus Health Plan Claims Database. This database comprises adjudicated claims for more than 150 million unique patients across the USA, with approximately 40 million active in the most recent calendar year and covering both pharmacy and medical claims. WitrynaIMS PharMetrics Plus. Cai et al (2016) 13 conducted another retrospective cohort study using IMS’ PharMetrics Plus Database to evaluate treatment patterns (adherence and persistence) in patients with T2DM that are newly initiating AHAs from February 2014 through June 2014. Patients were required to have ≥12 months pre-index and post …

WitrynaEligible patients were represented in the P+ and LRx datasets, had ≥1 claim for a statin (index claim) in either database, and had ≥ 24 months of continuous enrollment in … Witryna21 cze 2024 · This analysis utilized the Quintiles IMS Real‐World Data Adjudicated Claims (PharMetrics Plus) Database, which contains individual‐level, de‐identified healthcare claims information from health plans on more than 100 million commercially insured patients in the United States.

WitrynaIQVIA PharMetrics® Plus Comprehensive real world data on commercially insured patients in the US with a view into their diagnoses, treatments, and associated costs

Witryna2 lip 2024 · To identify potential changes to prescribing patterns and the extent of tamsulosin use for conditions beyond its original indication, we evaluated tamsulosin … cs4 photoshop macWitryna8 wrz 2024 · A retrospective claims-based analysis was conducted using IMS Pharmetrics Plus database. Included patients were ≥18 years old, with a diagnosis of ITP (2007-2012); an ITP-related claim for anti-D, intravenous immunoglobulin (IVIG), rituximab, romiplostim, or eltrombopag; and 1-year continuous enrollment (3-years for … dynamix gym cheritonWitryna6 sty 2024 · Methods: Patients with a VWD diagnosis who were users of or candidates for von Willebrand factor replacement were identified from the IMS PharMetrics Plus … cs4 photoshop move txtWitryna14 lip 2024 · This was a retrospective cohort study using IQVIA PharMetrics® Plus health plan claims database. The aggregated IQVIA PharMetrics Plus database is a nationally representative commercial claims database which comprises adjudicated medical and pharmacy claims of patients in the USA and is sourced directly from the … dynamix footballWitryna13 kwi 2024 · Experience on large databases (i.e. millions of records across multiple tables) Excellent R programming skills Experience supporting healthcare analytics using data, such as administrative insurance claims database and/or EMR databases (e.g., IBM-Truven, Optum, Humedica, IMS Pharmetrics +, GEhealth, Flatiron, etc.) dynamix group logoWitryna20 sie 2024 · a In the PharMetrics Plus database, there are patients covered by the Medicare Cost plan, also known as Medicare Gap or Medicare Supplemental. It is an insurance purchased by individuals to cover services not covered by … cs4 photo editingWitryna1 wrz 2024 · lation in the IMS PharMetrics Plus database was similar to the rate in Truven Health MarketScan ® Research data- base and ranged from 0.47 to 0.54% from 2006 to 2014. dynamix growth fund